Influx Healthtech is set to debut on the NSE SME platform today after its Rs 58.57 crore IPO. The IPO price was fixed at Rs 96 per share. The company, a CDMO established in 2020, offers manufacturing and product development services for nutraceuticals, cosmetics, and other healthcare products, operating from facilities in Thane, Maharashtra.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets